Prosecution Insights
Prosecution Insights
5 pending office actions • 4 clients • 5 examiners • 4 art units • 0 of 5 (0%) have an AI response strategy ready • 12 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (60%) |
| §112 only | 1 (20%) |
| No statute on record | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GABLER, PHILIP F | 1 | 73.4% | +24.0% |
| CANFIELD, ROBERT | 1 | 76.0% | +18.0% |
| ZEROUAL, OMAR | 1 | 34.0% | +40.0% |
| CHONG, KIMBERLY | 1 | 72.4% | +12.7% |
| PULLIAM, JOSEPH CONSTANTINE | 1 | 38.9% | +33.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18685466 | Zipped Flap Opening System | CANFIELD, ROBERT | 97d overdue |
| 16096997 | Machine Learning Algorithm for Identifying Peptides that Contain Features Positively Associated with Natural Endogenous or Exogenous Cellular Processing, Transportation and Histocompatibility Complex (MHC) Presentation | PULLIAM, JOSEPH CONSTANTINE | 56d overdue |
| 18455760 | SYSTEM, METHOD AND COMPUTER READABLE MEDIUM FOR INTERACTIONS BETWEEN AN EMPATHETIC PROFILE OF A DECEASED INDIVIDUAL AND A USER | ZEROUAL, OMAR | 28d overdue |
| 18715241 | Surface Chair | GABLER, PHILIP F | 18d overdue |
| 18449861 | Deuterium-Stabilised Ribonucleic Acid (RNA) Molecules Displaying Increased Resistance to Thermal and Enzymatic Hydrolysis, Aqueous Compositions Comprising Stabilised RNA Molecules and Methods for Making Same | CHONG, KIMBERLY | 14d |
| Client (Assignee) | Pending OAs |
|---|---|
| Ian Maley & Associates | 2 |
| Arbor Memorial | 1 |
| deutraMed Solutions Ltd. | 1 |
| ONCOIMMUNITY AS | 1 |
| Art Unit | Apps |
|---|---|
| 3636 | 2 |
| 3628 | 1 |
| 1636 | 1 |
| 1687 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18715241 | Surface Chair | Ian Maley & Associates Pty Ltd. | GABLER, PHILIP F | 3636 | §103 | Non-Final OA | 18d overdue | Pending | May 31, 2024 |
| 18685466 | Zipped Flap Opening System | Ian Maley & Associates Pty Ltd. | CANFIELD, ROBERT | 3636 | §112 | Non-Final OA | 97d overdue | Pending | Feb 21, 2024 |
| 18455760 | SYSTEM, METHOD AND COMPUTER READABLE MEDIUM FOR INTERACTIONS BETWEEN AN EMPATHETIC PROFILE OF A DECEASED INDIVIDUAL AND A USER | Arbor Memorial Inc. | ZEROUAL, OMAR | 3628 | §103 | Final Rejection | 28d overdue | Pending | Aug 25, 2023 |
| 18449861 | Deuterium-Stabilised Ribonucleic Acid (RNA) Molecules Displaying Increased Resistance to Thermal and Enzymatic Hydrolysis, Aqueous Compositions Comprising Stabilised RNA Molecules and Methods for Making Same | Deutramed Solutions Ltd. | CHONG, KIMBERLY | 1636 | Other | Non-Final OA | 14d | Pending | Aug 15, 2023 |
| 16096997 | Machine Learning Algorithm for Identifying Peptides that Contain Features Positively Associated with Natural Endogenous or Exogenous Cellular Processing, Transportation and Histocompatibility Complex (MHC) Presentation | Oncoimmunity AS | PULLIAM, JOSEPH CONSTANTINE | 1687 | §103 | Non-Final OA | 56d overdue | Pending | Oct 26, 2018 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial